Accueil   Diary - News   All news Synthelis & Sanofi Pasteur sign a partnership agreement

Synthelis & Sanofi Pasteur sign a partnership agreement

 

 

                             

 

Synthelis announces the signature of a Partnership with Sanofi Pasteur

 

 

 

After a three year period where Sanofi evaluated Synthelis’ cell-free technology as a potential key enabling technology to develop some of the next generation vaccines, this interest is now confirmed. Both entities established indeed a collaborative program to adapt the protein expression system to the industrial requirements of the vaccine industry

 

“We are very glad to have reached this step with a client like Sanofi Pasteur. We were in a supplier – client relationship since 2011, we are now starting a co-development phase together which will strongly enhanced the added value of Synthelis’ technology and know-how” says Bruno Tillier, President, co-founder of Synthelis.

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree